Skip to main content
Premium Trial:

Request an Annual Quote

Moore Foundation Awards ASU Researchers $1.8M to Develop Microscopy Technology

NEW YORK (GenomeWeb News) – The Gordon and Betty Moore Foundation has awarded researchers at Arizona State University's Biodesign Institute $1.8 million for the development of new microscopy technology for capturing molecular-level events in living systems.

The funding for three years was awarded to Nongjian Tao for a project titled "Label-free imaging and tracking of single protein-protein interactions" and will be used to develop a microscopy system based, in part, on plasmonic resonance. Tao directs Biodesign's Center for Bioelectronics and Biosensors.

He and his fellow researchers will develop a fast and low-noise plasmonic imaging system that can resolve fine structures and follow the transport of sub-cellular features "with startling precision, with temporal resolution in the sub-millisecond range," ASU said.

According to the university, the technology will allow researchers to observe "a specimen's form" at a molecular level and to investigate chemical reactions and charge-related properties of living systems.

As part of the project, Tao will track the movement of mitochondria in a living cell, which could lead to new insights into the interaction of motor proteins between mitochondria and microtubules, as well as other molecular-scale events.

The Scan

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.

Meta AI Computer Model Rapidly Predicts Hundreds of Millions of Metagenomic Proteins

Meta AI researchers describe in Science a new large language model that can predict the structures of millions of metagenomic proteins.

Hutch Team Develops Platform for Assessing Impact of SARS-CoV-2 Spike Mutations

The approach described in Cell relies on lentiviral pseudotyping for mutational scanning, which the researchers applied to the SARS-CoV-2 spike protein.

Potential New Therapeutic Target for Rheumatoid Arthritis Discovered

Researchers report in the American Journal of Human Genetics that SNPs implicated in rheumatoid arthritis often regulate the expression of the inflammation-related SPRED2 gene.